Anthrax. From bioweapons backwater to main attraction.
Bohannon
John
J
D000818:Animals; D000881:Anthrax / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D022122:Anthrax Vaccines; D000942:Antigens, Bacterial; D000992:Antitoxins / Q000276:immunology / Q000627:therapeutic use; D001408:Bacillus anthracis / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity / Q000502:physiology; D001426:Bacterial Proteins / Q000235:genetics; D001427:Bacterial Toxins / Q000235:genetics / Q000276:immunology; D001694:Biological Warfare; D023482:Bioterrorism; D024881:Drug Resistance, Bacterial; D015964:Gene Expression Regulation, Bacterial; D005798:Genes, Bacterial; D016680:Genome, Bacterial; D006801:Humans; D009500:Neutralization Tests; D010957:Plasmids; D013171:Spores, Bacterial / Q000502:physiology; D015534:Trans-Activators / Q000235:genetics; D014611:Vaccination; D019444:Vaccines, DNA
C082932:ATXA protein, Bacillus anthracis; D022122:Anthrax Vaccines; D000942:Antigens, Bacterial; D000992:Antitoxins; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D015534:Trans-Activators; D019444:Vaccines, DNA; C030325:anthrax toxin